RAD54L2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.66829883241348E-11 |
Normal-vs-Stage2 |
1.30749999716073E-08 |
Normal-vs-Stage3 |
<1E-12 |
Normal-vs-Stage4 |
1.62447832963153E-12 |
Stage1-vs-Stage2 |
2.452600E-01 |
Stage1-vs-Stage3 |
8.71120000023318E-07 |
Stage1-vs-Stage4 |
2.154199999993E-05 |
Stage2-vs-Stage3 |
9.024000E-02 |
Stage2-vs-Stage4 |
8.533500E-02 |
Stage3-vs-Stage4 |
8.538800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62470037423645E-12 |
Normal-vs-AfricanAmerican |
2.64520000348156E-08 |
Normal-vs-Asian |
1.995440E-01 |
Caucasian-vs-AfricanAmerican |
6.965200E-01 |
Caucasian-vs-Asian |
4.949500E-02 |
AfricanAmerican-vs-Asian |
1.494850E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.11022302462516E-16 |
Normal-vs-Female |
1.63091762317435E-12 |
Male-vs-Female |
2.111400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.48030000002297E-06 |
Normal-vs-Age(41-60Yrs) |
3.82305298529673E-12 |
Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
Normal-vs-Age(81-100Yrs) |
6.89360002414929E-09 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.238000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.496400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.037800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.749900E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.467900E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.054800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.489220E-01 |
Normal-vs-Grade 2 |
2.8244073746464E-13 |
Normal-vs-Grade 3 |
1.62458935193399E-12 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
2.986500E-02 |
Grade 1-vs-Grade 3 |
1.463410E-03 |
Grade 1-vs-Grade 4 |
9.6216999999954E-05 |
Grade 2-vs-Grade 3 |
2.773800E-02 |
Grade 2-vs-Grade 4 |
7.366000E-04 |
Grade 3-vs-Grade 4 |
1.088760E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.62680979798324E-12 |
Normal-vs-ccB subtype |
1.17579945779767E-10 |
ccA subtype-vs-ccB subtype |
8.250000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.63713487211226E-12 |
Normal-vs-N1 |
3.26019999996596E-06 |
N0-vs-N1 |
3.224000E-01 |
|
|